DCP backs China expansion by Canadian vitamins brand
DCP Capital has agreed to invest approximately USD 175m to support the China expansion of Jamieson Wellness, a listed Canadian producer of health and wellness products.
The China-focused GP will pay USD 35m for a one-third stake in Jamieson’s China operation and subscribe to USD 75m worth of preferred shares in Jamieson itself. In addition, DCP will subscribe to warrants...
More on Greater China
Latest News
Japan's Heartseed raises $14m Series D
Heartseed, a Tokyo-based biotech start-up specializing in treatments that use cardiac muscle cells to initiate the remuscularization of patients who have suffered heart failure, has raised JPY 2bn (USD 14.3m) in Series D funding.
Shenzhen Capital backs Chinese titanium metal producer
Shenzhen Capital Group has participated in a CNY 2.27bn (USD 321m) funding round for Yunnan National Titanium Metal, a subsidiary of Shenzhen-listed chemicals producer LB Group.
Indonesia e-commerce player Evermos gets $39m Series C
The International Finance Corporation (IFC) has led a USD 39m Series C round for Evermos, an Indonesian social commerce platform that positions itself as an impact play.
Singapore's Qualgro seeks $150m for Fund III
Qualgro Partners, a Singapore-headquartered venture capital firm, is looking to raise USD 150m for its third fund.